Coverage Timeline 14 articles
FDA Rejects Rare Disease Drug, While Sperm Study Finds Seasonal Patterns
Summer boost to sperm quality and a top health official's hopes for prior authorization reform
Novo's Obesity Drug Shows Promise as FDA Weighs Changes
New study results and regulatory developments in the pharmaceutical industry
Brain Implants and Rare Disease Drugs Face Regulatory Hurdles
The FDA is facing criticism for its recent rejections of rare disease drugs and brain implant technologies, sparking debate over the agency's regulatory approach.
FDA Rejects Rare Blood Cancer Therapy Despite Internal Approval
The FDA has rejected an experimental therapy for a rare blood cancer, contradicting the recommendation of its internal reviewers, sparking confusion and raising questions about the agency's review process.
FDA Unveils Rules for Bespoke Gene Therapies
New pathway expected to spur applications for rare disease treatments
Health Care Under the Microscope
As the midterms approach, health care is in the spotlight, with lobbyists targeting the FDA, AI devices potentially bypassing review, and reform efforts facing an uphill battle.
FDA Defends Rare Disease Drug Rejections Amid Criticism
FDA Commissioner Marty Makary defends the agency's recent rejections of rare disease drugs, amid criticism from patient advocates and lawmakers.
Trump's Influence Reaches Far and Wide, From the Olympics to the FDA and Beyond
From the Winter Olympics to the FDA, and from academia to international diplomacy, the influence of Donald Trump is being felt far and wide. The latest developments show that his words and actions continue to have significant repercussions, sparking controversy and debate on multiple fronts.
New York Mayor Threatens Property Tax Hike as FDA Reverses Stance on Moderna's mRNA Flu Vaccine
New York Mayor Zohran Mamdani has proposed a 9.5% property tax increase as a "last resort" if a wealth tax isn't passed, while the FDA has reversed its decision to review Moderna's mRNA-based flu vaccine. The move comes as Governor Kathy Hochul faces re-election this year. Meanwhile, the FDA's reversal on the flu vaccine has sparked relief in the medical industry.
FDA Reverses Course on Moderna's mRNA Flu Shot, While Google Unveils AI Music Model Lyria 3
In a surprising turn of events, the FDA has decided to review Moderna's mRNA flu shot after initially rejecting it, while Google is set to launch its AI music model Lyria 3, capable of generating 30 seconds of music with a simple prompt.
Turmoil in America: FDA Controversy, University Cuts, and High-Stakes Investigations
A series of controversies is rocking the United States, from the FDA's refusal to consider Moderna's flu shot application to the shutdown of gender studies courses at universities and the Epstein files' potential impact on Jamie Dimon's reputation. Meanwhile, the launch of an AI freight tool has sent shockwaves through the trucking and logistics industries, and the Justice Department is dropping charges against two men accused of hitting an ICE officer in Minnesota.
Turmoil in America: FDA Rejects Moderna Flu Shot, Universities Cut Gender Studies, and AI Disrupts Industries
The FDA's surprise rejection of Moderna's flu shot application has sparked concerns about the agency's stance on vaccines, while universities across the US are shutting down gender studies programs. Meanwhile, the launch of an AI freight tool has sent shares in trucking and logistics firms plummeting, and the Justice Department has moved to drop charges against two men accused of hitting an ICE officer in Minnesota.
Europe's Ariane 6 Rocket Delivers for Amazon, While Tech and Science Worlds See Major Developments
In a week marked by significant advancements and setbacks, Europe's Ariane 6 rocket successfully launched, OpenAI unveiled a faster coding model, and the FDA faced controversy over a rejected flu shot. Meanwhile, the entertainment world got a glimpse of the upcoming Spider-Noir film, and ULA's Vulcan rocket experienced another booster problem.
Space Exploration and Tech Advancements Take Center Stage Amidst Controversy and Innovation
From the successful launch of Europe's Ariane 6 rocket to OpenAI's breakthrough coding model, this week has seen significant advancements in space exploration and technology. However, controversy surrounds the FDA's rejection of Moderna's flu shot, while the film industry teases a new Spider-Man spinoff. Meanwhile, ULA's Vulcan rocket faces another setback on its way to orbit.